PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro

被引:23
作者
Shao, Li-tao [1 ]
Luo, Liang [2 ]
Qiu, Jie-hong [3 ]
Deng, David Y. B. [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Sci Res Ctr, Shenzhen, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Crit Care Med, Shenzhen, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Obstet & Gynecol, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteoarthritis; Parathyroid hormone; Exosome; Chondrocyte; CARTILAGE; OSTEOARTHRITIS; INFLAMMATION;
D O I
10.1186/s13075-022-02778-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The effects of bone marrow mesenchymal stem cells (BMSCs) during the treatment of cartilage damage have been proven to be attributed to paracrine mechanisms, particularly the effect of exosomes. Exosomes from different batches are inhomogeneous, and different treatment effects are observed between samples. The purpose of this research was to find more effective and homogeneous exosomes for the repair of chondrocytes in osteoarthritis (OA). We observed the potential effects and possible mechanisms of exosomes derived from parathyroid hormone (PTH) (1-34)-preconditioned BMSCs (Exo(PTH)) in the alleviation of OA. Materials and methods Exosomes derived from BMSCs (Exo(BMSC)) and Exo(PTH) were isolated by differential centrifugation. Primary rat chondrocytes were used to establish the OA model by interleukin 1 beta (IL-1 beta) in vitro. The effects of these two types of exosomes on OA chondrocyte proliferation, migration, apoptosis, and extracellular matrix formation were measured and compared. We observed changes in IL-2, TNF-alpha, and IL-6 levels via Western blotting (WB), and quantitative real-time PCR (qRT-PCR). Results We successfully extracted Exo(BMSC) and Exo(PTH) and established an IL-1 beta-induced OA model in primary chondrocytes from rats. Our study showed that IL-2, TNF-alpha, and IL-6 levels increased significantly in OA chondrocytes; however, both Exo(BMSC) and Exo(PTH) reduced the levels of IL-2, TNF-alpha, and IL-6. In addition, Exo(PTH) exhibited stronger anti-inflammatory effects. Exo(PTH) had a more marked effect on proliferation, migration, and production of the extracellular matrix (Col-II) in OA chondrocytes than Exo(BMSC) at 24 h. Conclusion Exo(PTH) increased the migration, proliferation, and chondral matrix formation of OA chondrocytes in vitro. In OA chondrocyte therapy, the potential mechanism of Exo(PTH) might involve the inhibition of production of proinflammatory cytokines. Although the two types of exosomes had some similar effects, most effects of Exo(PTH) were better than those of Exo(BMSC), so Exo(PTH) may have a better ability to alleviate OA.
引用
收藏
页数:13
相关论文
共 46 条
  • [1] The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes
    Alquraini, Ali
    Jamal, Maha
    Zhang, Ling
    Schmidt, Tannin
    Jay, Gregory D.
    Elsaid, Khaled A.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [2] Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy
    Bari, Elia
    Perteghella, Sara
    Catenacci, Laura
    Sorlini, Marzio
    Croce, Stefania
    Mantelli, Melissa
    Avanzini, Maria A.
    Sorrenti, Milena
    Torre, Maria L.
    [J]. NANOMEDICINE, 2019, 14 (06) : 753 - 765
  • [3] Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15
    Bocelli-Tyndall, C.
    Bracci, L.
    Schaeren, S.
    Feder-Mengus, C.
    Barbero, A.
    Tyndall, A.
    Spagnoli, G. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1352 - 1359
  • [4] Evidence that TNF-β ( lymphotoxin α) can activate the inflammatory environment in human chondrocytes
    Buhrmann, Constanze
    Shayan, Parviz
    Aggarwal, Bharat B.
    Shakibaei, Mehdi
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [5] Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
    Cai, DS
    Yuan, MS
    Frantz, DF
    Melendez, PA
    Hansen, L
    Lee, J
    Shoelson, SE
    [J]. NATURE MEDICINE, 2005, 11 (02) : 183 - 190
  • [6] Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
    Chapuis, J.
    Hot, D.
    Hansmannel, F.
    Kerdraon, O.
    Ferreira, S.
    Hubans, C.
    Maurage, C. A.
    Huot, L.
    Bensemain, F.
    Laumet, G.
    Ayral, A. M.
    Fievet, N.
    Hauw, J. J.
    DeKosky, S. T.
    Lemoine, Y.
    Iwatsubo, T.
    Wavrant-Devrieze, F.
    Dartigues, J. F.
    Tzourio, C.
    Buee, L.
    Pasquier, F.
    Berr, C.
    Mann, D.
    Lendon, C.
    Alperovitch, A.
    Kamboh, M. I.
    Amouyel, P.
    Lambert, J. C.
    [J]. MOLECULAR PSYCHIATRY, 2009, 14 (11) : 1004 - 1016
  • [7] Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3
    Chen, Xue
    Shi, Yuanyuan
    Xue, Pan
    Ma, Xinli
    Li, Junfeng
    Zhang, Jun
    [J]. ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [8] Parathyroid Hormone-Induced Bone Marrow Mesenchymal Stem Cell Chondrogenic Differentiation and its Repair of Articular Cartilage Injury in Rabbits
    Chen, Yushu E. Q. D.
    Chen, Yi
    Zhang, Shujiang
    Du, Xiufan
    Bai, Bo
    [J]. MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2016, 22 : 132 - 145
  • [9] Characterization and immunosuppressive properties of mesenchymal stem cells from periapical lesions
    Dokic, Jelena
    Tomic, Sergej
    Cerovic, Snezana
    Todorovic, Vera
    Rudolf, Rebeka
    Colic, Miodrag
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2012, 39 (09) : 807 - 816
  • [10] Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model
    Fei, Junliang
    Liang, Bin
    Jiang, Chunzhi
    Ni, Haifeng
    Wang, Liming
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1586 - 1592